1. MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
   Kamila Kitowska et al, 2021, Frontiers in Oncology CrossRef
2. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery
   Tong Zhu et al, 2021, Virchows Archiv CrossRef
3. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation
   Pingfeng Chen et al, 2021, Cancer Immunology, Immunotherapy CrossRef